307 related articles for article (PubMed ID: 22503553)
21. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
22. Endocrine disruptor regulation of microRNA expression in breast carcinoma cells.
Tilghman SL; Bratton MR; Segar HC; Martin EC; Rhodes LV; Li M; McLachlan JA; Wiese TE; Nephew KP; Burow ME
PLoS One; 2012; 7(3):e32754. PubMed ID: 22403704
[TBL] [Abstract][Full Text] [Related]
23. Maturation of microRNA is hormonally regulated by a nuclear receptor.
Yamagata K; Fujiyama S; Ito S; Ueda T; Murata T; Naitou M; Takeyama K; Minami Y; O'Malley BW; Kato S
Mol Cell; 2009 Oct; 36(2):340-7. PubMed ID: 19854141
[TBL] [Abstract][Full Text] [Related]
24. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.
Irish JC; Mills JN; Turner-Ivey B; Wilson RC; Guest ST; Rutkovsky A; Dombkowski A; Kappler CS; Hardiman G; Ethier SP
Mol Oncol; 2016 Jun; 10(6):850-65. PubMed ID: 27005559
[TBL] [Abstract][Full Text] [Related]
25. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.
Zhao Y; Deng C; Lu W; Xiao J; Ma D; Guo M; Recker RR; Gatalica Z; Wang Z; Xiao GG
Mol Med; 2011; 17(11-12):1233-41. PubMed ID: 21826373
[TBL] [Abstract][Full Text] [Related]
26. Regulation of estrogen receptor (ER) isoform messenger RNA expression by different ER ligands in female rat pituitary.
Tena-Sempere M; Navarro VM; Mayen A; Bellido C; Sánchez-Criado JE
Biol Reprod; 2004 Mar; 70(3):671-8. PubMed ID: 14613904
[TBL] [Abstract][Full Text] [Related]
27. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines.
Adams BD; Furneaux H; White BA
Mol Endocrinol; 2007 May; 21(5):1132-47. PubMed ID: 17312270
[TBL] [Abstract][Full Text] [Related]
28. Distinct expressions of microRNAs that directly target estrogen receptor α in human breast cancer.
Yoshimoto N; Toyama T; Takahashi S; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Breast Cancer Res Treat; 2011 Nov; 130(1):331-9. PubMed ID: 21755340
[TBL] [Abstract][Full Text] [Related]
29. Estrogen regulates luminal progenitor cell differentiation through H19 gene expression.
Basak P; Chatterjee S; Weger S; Bruce MC; Murphy LC; Raouf A
Endocr Relat Cancer; 2015 Aug; 22(4):505-17. PubMed ID: 25944846
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.
Patki M; Salazar Md; Trumbly R; Ratnam M
Biochem Biophys Res Commun; 2015 Feb; 457(3):404-11. PubMed ID: 25582774
[TBL] [Abstract][Full Text] [Related]
31. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.
Maillot G; Lacroix-Triki M; Pierredon S; Gratadou L; Schmidt S; Bénès V; Roché H; Dalenc F; Auboeuf D; Millevoi S; Vagner S
Cancer Res; 2009 Nov; 69(21):8332-40. PubMed ID: 19826037
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
33. Role of miR-203 in estrogen receptor-mediated signaling in the rat uterus and endometrial carcinoma.
Zierau O; Helle J; Schadyew S; Morgenroth Y; Bentler M; Hennig A; Chittur S; Tenniswood M; Kretzschmar G
J Cell Biochem; 2018 Jul; 119(7):5359-5372. PubMed ID: 29331043
[TBL] [Abstract][Full Text] [Related]
34. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
[TBL] [Abstract][Full Text] [Related]
35. Novel ligands balance estrogen receptor β and α agonism for safe and effective suppression of the vasomotor response in the ovariectomized female rat model of menopause.
McGregor C; Sau A; Ruddy SC; Leung D; Webb M; Durst T; Wright JS; Lagace D; Pratt MA
Endocrinology; 2014 Jul; 155(7):2480-91. PubMed ID: 24823389
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.
Cochrane DR; Cittelly DM; Howe EN; Spoelstra NS; McKinsey EL; LaPara K; Elias A; Yee D; Richer JK
Horm Cancer; 2010 Dec; 1(6):306-19. PubMed ID: 21761362
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
[TBL] [Abstract][Full Text] [Related]
38. Expression of miR-206 during the initiation of mammary gland development.
Lee MJ; Yoon KS; Cho KW; Kim KS; Jung HS
Cell Tissue Res; 2013 Sep; 353(3):425-33. PubMed ID: 23733266
[TBL] [Abstract][Full Text] [Related]
39. miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer.
Kondo N; Toyama T; Sugiura H; Fujii Y; Yamashita H
Cancer Res; 2008 Jul; 68(13):5004-8. PubMed ID: 18593897
[TBL] [Abstract][Full Text] [Related]
40. A human estrogen receptor (ER)alpha mutation with differential responsiveness to nonsteroidal ligands: novel approaches for studying mechanism of ER action.
Paulmurugan R; Tamrazi A; Katzenellenbogen JA; Katzenellenbogen BS; Gambhir SS
Mol Endocrinol; 2008 Jul; 22(7):1552-64. PubMed ID: 18451095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
